2m 2m 2m 2m 2m 2m 2m
TRANSCODE THERA (RNAZ)
NASDAQ
$8.61+$0.05 (+0.58%)
Price as of Jul 13, 2026 5:47 PM EDT- $8.1MMarket Cap
- -6.04%1-Year Change
- BiotechnologyIndustry
TRANSCODE THERA (RNAZ)
$8.61+$0.05 (+0.58%)
RNAZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.56 | ||
Change | -$0.27 (-3.06%) | ||
Open | $8.79 | ||
High | $9.12 | ||
Low | $7.94 | ||
Previous Close | $8.83 | ||
Volume | 25,209 | ||
30-Day Average Volume | 32,985 | ||
1-Week Change | 10.17% | ||
1-Month Change | 60.60% | ||
1-Year Change | -6.04% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 950,302 | ||
Total Assets | $157.2M | ||
Market Cap | $8.1M | ||
Enterprise Value | -$4.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$5.0M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.5M | ||
Net Working Capital | $11.4M | ||
EPS | -$21.28 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 28 | ||
Last Split Date | 05/15/2025 | ||
Earnings & Revenue